Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radiotherapy for prostate cancer and sexual functioning.

Luca Incrocci1

  • 1Radiation Oncologist, Erasmus MC-Daniel den Hoed Cancer Center, Department of Radiation Oncology, Rotterdam, The Netherlands.

Hospital Medicine (London, England : 1998)
|November 5, 2004
PubMed
Summary

Erectile dysfunction is common after prostate cancer radiotherapy. Pre-treatment function and multifactorial causes are key, with treatments like sildenafil available.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiation-Induced Vaginal Stenosis in Patients With Cervical Cancer in Low- and Middle-Income Countries: A Scoping Review.

International journal of radiation oncology, biology, physics·2026
Same author

Radiobiological Modeling for Acute Proctitis After Conventional and Hypofractionated Radiation Therapy for Prostate Cancer.

International journal of radiation oncology, biology, physics·2025
Same author

Hypofractionated Dose Escalation Versus Conventionally Fractionated Radiation Therapy for Patients With Intermediate- and High-Risk Localized Prostate Cancer: Long-Term Results of the HYPRO Trial.

International journal of radiation oncology, biology, physics·2025
Same author

Efficacy of Treatments for T3bN0M0 Prostate Cancer Patients: A Systematic Review and Meta-Analysis.

The Prostate·2025
Same author

A comparative analysis of hypofractionated versus conventional radiotherapy for cervical cancer in a resource-limited setting: a prospective study.

Frontiers in oncology·2025
Same author

Challenges and opportunities to minimize the dose in the neurovascular bundles during prostate radiotherapy.

Clinical and translational radiation oncology·2025

Area of Science:

  • Oncology
  • Urology
  • Men's Health

Background:

  • Radiotherapy for prostate cancer frequently leads to erectile dysfunction.
  • Understanding the multifactorial causes is crucial for effective management.
  • Pre-treatment erectile function significantly impacts post-treatment outcomes.

Purpose of the Study:

  • To highlight the high incidence of erectile dysfunction post-prostate cancer radiotherapy.
  • To emphasize the importance of considering multifactorial etiology, including baseline erectile function.
  • To inform patients about available treatment options for post-radiotherapy erectile dysfunction.

Main Methods:

  • Review of existing literature on prostate cancer radiotherapy and erectile dysfunction.
  • Analysis of factors contributing to erectile dysfunction.
  • Identification of effective treatment modalities.

Main Results:

  • High incidence of erectile dysfunction observed following radiotherapy.
  • Erectile dysfunction etiology is multifactorial, influenced by pre-treatment function.
  • Effective treatments such as sildenafil and intracavernosal injections are identified.

Conclusions:

  • Erectile dysfunction is a significant concern after prostate cancer radiotherapy.
  • Comprehensive assessment considering pre-treatment function is necessary.
  • Patient education on treatment options like sildenafil and intracavernosal injections is vital.

Related Experiment Videos